About ITM
ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer...
Regulatory Affairs Manager (gn) Design Control
Formycon is an international leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. With an experienced team comprised of around 240 highly skilled profess...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
Head of Regulatory Affairs CMC Drug Product (gn)
Manager First Level
Medicine, Pharmacy, Laboratory
Quality Management, Quality Assurance
Formycon is an international leading, independent developer of high-quality biopharmaceutical medicin...
Head of Regulatory Affairs CMC Drug Product (gn)
Manager First Level
Medicine, Pharmacy, Laboratory
Quality Management, Quality Assurance
Formycon is an international leading, independent developer of high-quality biopharmaceutical medicin...
About ITM
ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer ...
About ITM
ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer ...
Regulatory Affairs Manager (gn) Design Control
Formycon is an international leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. With an experienced team comprised of around 240 highly skilled profess...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
Ihr Universitätsklinikum im Herzen Münchens
Wir sind das Klinikum rechts der Isar (MRI) der Technischen Universität München (TUM ) und verlässlicher Arbeitgeber für rund 6.600 Mitarbeiter*innen. Als Uniklinikum widmen wir uns neben der Krankenve...
